8-K - Sana Biotechnology, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

, including the attached Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934,

Financial Results

8.01

Other Events. On March 3, 2026, the Company entered into an amended and restated sales agreement (the “Sales Agreement”) with TD Securities (USA) LLC (“TD Cowen

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 1.1 Amended and Restated Sales Agreement by and between Sana Biotechnology, Inc. and TD

Exhibits Only

Exhibits (3)

1.1

EX-1.1

8-K

99.1

EX-99.1